Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections | Zendy

Dokyun Kim | Zendy; Jun Sung Hong | Zendy; Eun-Jeong Yoon | Zendy; Hyukmin Lee | Zendy; Young Ah Kim | Zendy; Kyeong Seob Shin | Zendy; Jeong Hwan Shin | Zendy; Young Uh | Zendy; Jong Hee Shin | Zendy; Yoon Soo Park | Zendy; Seok Hoon Jeong | Zendy

Open Access

Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections

Author(s) -

Dokyun Kim,

Jun Sung Hong,

Eun-Jeong Yoon,

Hyukmin Lee,

Young Ah Kim,

Kyeong Seob Shin,

Jeong Hwan Shin,

Young Uh,

Jong Hee Shin,

Yoon Soo Park,

Seok Hoon Jeong

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01362-19

Subject(s) - staphylococcus aureus , medicine , bacteremia , odds ratio , carriage , blood culture , staphylococcal infections , methicillin resistant staphylococcus aureus , mortality rate , confidence interval , toxic shock syndrome , microbiology and biotechnology , biology , antibiotics , pathology , bacteria , genetics

This study was performed to evaluate the clinical impacts of putative risk factors in patients withStaphylococcus aureus bloodstream infections (BSIs) through a prospective, multicenter, observational study. All 567 patients withS. aureus BSIs that occurred during a 1-year period in six general hospitals were included in this study. Host- and pathogen-related variables were investigated to determine risk factors for the early mortality of patients withS. aureus BSIs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research